JADENU

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 42bc7f0cc7d2524e
Drug Approval Canada Name: JADENU
Product Name: JADENU
Status: Marketed
Status Date: 2016-03-24
Original Market Date: 2016-03-24
Din: 02452235
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 64:00.00
Atc Original: V03AC03 DEFERASIROX
Atc Name: v 03 ac 03
Aig Number: 0151733006
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

DEFERASIROX

360 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

42bc7f0cc7d2524e

Type

Standard